Bayzed Health Group Inc (HKG:2609)
Hong Kong · Delayed Price · Currency is HKD 3.015
-0.045 (-1.47%)
Sep 2, 2026, 4:08 PM HKT
Bayzed Health Group Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 556.28 | 615.97 | 294.24 | 241.99 | 125.19 | 166.05 |
Short-Term Investments | - | 5.01 | 6.86 | 4.34 | 5.12 | 6.25 |
Cash & Short-Term Investments | 556.28 | 620.98 | 301.1 | 246.33 | 130.3 | 172.3 |
Cash Growth | -33.40% | 106.23% | 22.24% | 89.04% | -24.37% | - |
Accounts Receivable | 233.89 | 238.63 | 262.09 | 196.34 | 198.91 | 107.73 |
Other Receivables | - | 220.19 | 92.53 | 9.88 | 14.7 | 31.04 |
Receivables | 233.89 | 458.81 | 354.62 | 391.64 | 394.23 | 322.87 |
Inventory | 56.63 | 72.56 | 78.68 | 72.13 | 68.06 | 38.69 |
Restricted Cash | 8.16 | 8.62 | 18.27 | 20.62 | 20.57 | 20.51 |
Other Current Assets | - | - | 5.32 | 2.46 | 0.64 | 5.5 |
Total Current Assets | 1,147 | 1,161 | 757.99 | 733.18 | 613.8 | 559.87 |
Property, Plant & Equipment | 477.42 | 513.06 | 548.91 | 579.94 | 599.26 | 413.85 |
Goodwill | 643.05 | 643.05 | 643.05 | 643.05 | 643.05 | 507.47 |
Other Intangible Assets | 222.02 | 227.74 | 236.4 | 243.42 | 247.44 | 228.54 |
Long-Term Deferred Tax Assets | 7.02 | 6.45 | 6.77 | 5.66 | 4.69 | 2.64 |
Other Long-Term Assets | 29.47 | 4.86 | 9.98 | 6.16 | 2.71 | 52.31 |
Total Assets | 2,526 | 2,556 | 2,203 | 2,211 | 2,111 | 1,765 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 217.12 | 224.26 | 313.88 | 251.23 | 264.25 | 154.1 |
Accrued Expenses | - | 57.88 | 67.68 | 67.43 | 55.96 | 25.47 |
Short-Term Debt | - | 0.09 | - | 1.5 | 48.01 | 26.93 |
Current Portion of Long-Term Debt | 345.25 | 327.19 | 292.09 | 257.31 | 202.01 | 61.4 |
Current Portion of Leases | 16.56 | 18.93 | 22.91 | 22 | 21.37 | 27.06 |
Current Income Taxes Payable | 5.93 | 6.6 | 6.98 | 15.75 | 16.76 | 8.75 |
Current Unearned Revenue | 6.98 | 12.57 | 30.74 | 75.58 | 83.38 | 9.28 |
Other Current Liabilities | 86.04 | 41.38 | 47.49 | 44.6 | 50.74 | 42.38 |
Total Current Liabilities | 677.88 | 688.89 | 781.77 | 735.39 | 742.46 | 355.37 |
Long-Term Debt | 59.5 | 74 | 65.1 | 94.04 | 74.37 | 111.22 |
Long-Term Leases | 115.56 | 124.28 | 137.16 | 156.91 | 159.87 | 149.21 |
Long-Term Deferred Tax Liabilities | 47.74 | 48.44 | 48.99 | 49.54 | 47.77 | 44.46 |
Total Liabilities | 900.68 | 935.62 | 1,033 | 1,036 | 1,024 | 660.26 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.09 | 0.09 | 0.08 | 0.08 | 0.04 | 0.04 |
Additional Paid-In Capital | - | 624.25 | 135.18 | 135.18 | 6.67 | - |
Retained Earnings | 1,521 | -319.16 | -306.2 | -292.75 | -266.36 | -208.34 |
Comprehensive Income & Other | - | 1,215 | 1,240 | 1,242 | 1,248 | 1,231 |
Total Common Equity | 1,522 | 1,520 | 1,069 | 1,084 | 987.9 | 1,022 |
Minority Interest | 103.89 | 100.15 | 100.83 | 91.39 | 98.59 | 82.07 |
Shareholders' Equity | 1,625 | 1,621 | 1,170 | 1,176 | 1,086 | 1,104 |
Total Liabilities & Equity | 2,526 | 2,556 | 2,203 | 2,211 | 2,111 | 1,765 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 536.88 | 544.48 | 517.26 | 531.77 | 505.62 | 375.82 |
Net Cash (Debt) | 19.4 | 76.49 | -216.15 | -285.44 | -375.32 | -203.52 |
Net Cash Growth | -92.52% | - | - | - | - | - |
Net Cash Per Share | 0.02 | 0.06 | -0.18 | -0.24 | - | - |
Filing Date Shares Outstanding | 1,442 | 1,318 | 1,185 | 1,185 | - | - |
Total Common Shares Outstanding | 1,442 | 1,318 | 1,185 | 1,185 | - | - |
Working Capital | 469.29 | 472.07 | -23.78 | -2.21 | -128.66 | 204.5 |
Book Value Per Share | 1.06 | 1.15 | 0.90 | 0.91 | - | - |
Tangible Book Value | 656.51 | 649.58 | 189.8 | 197.66 | 97.41 | 286.35 |
Tangible Book Value Per Share | 0.46 | 0.49 | 0.16 | 0.17 | - | - |
Buildings | - | 79.37 | 79.37 | 79.37 | 79.37 | - |
Machinery | - | 276.15 | 249.34 | 220.78 | 192.3 | 117.7 |
Construction In Progress | - | 5.65 | 5.58 | 8.33 | 3.49 | 12.46 |
Leasehold Improvements | - | 250.94 | 242.46 | 229.32 | 221.55 | 174.02 |